After applying the tool and comparing the data with the biopsy findings, UCSF researchers reduced the number of benign biopsies or false-positives by 60%, from 55 to 22.
The needs assessment was conducted using key informant interviews and an internet-based survey distributed to the UCSF CER listserv and other investigators. Four major issues emerged as barriers.